1. Field of the Invention
The present disclosure is directed generally to systems and methods for performing acoustic hemostasis on bleeding trauma in limbs.
2. Description of the Related Art
Certain injurious events result in bleeding penetration wounds in the limbs of the human body, for example military combat bullet and shrapnel wounds, vehicular accidents, and insertion of penetrating devices (needles and catheters) into tissue during medical procedures, such as blood vessels and/or organs. Following such injuries, it is desirable to rapidly stop the bleeding from these wounds (hemostasis), especially bleeding from puncture wounds of significant blood vessels, and to do so in an efficient manner, minimizing time and effort.
One embodiment disclosed herein includes an ultrasound applicator that comprises a two-dimensional array of electrostrictive transducer elements and at least one diode electrically connected to each transducer element.
Another embodiment disclosed herein includes a method of driving the ultrasound applicator described above by forward biasing at least one diode connected to a transducer element that is desired to be driven.
Another embodiment disclosed herein includes an ultrasound applicator that comprises a plurality of electrostrictive ultrasound transducer elements, each element comprising an electrostrictive material and a bypass capacitor electrically connected to at least one element, wherein the bypass capacitor comprises an electrostrictive material between two conductive plates.
Another embodiment disclosed herein includes a method of driving an electrostrictive ultrasound transducer array, comprising voltage biasing a first set of selected electrostrictive transducer elements within the array and electrically shorting a second set of selected electrostrictive transducer elements within the array.
Inflatable Cuff with Ultrasound Applicator for Hemostasis
Various embodiments provide devices and methods for optimally treating bleeding wounds in injured limbs with acoustic hemostasis using high intensity focused ultrasound. It has been discovered that raising tissue and blood temperatures to threshold levels for a sustained and appropriate dosing time can be used to stop traumatic bleeding in a controlled, reliable manner. Although blood coagulation can be achieved at modest sustained elevated temperatures (≈T>46° C.), at these temperatures, a long heating time is required and blood itself is a poor absorber of ultrasound energy (e.g., αblood≈0.03 Np/cm/MHz as compared to αmuscle≈0.15 Np/cm/MHz where α is the acoustic absorption coefficient. Therefore, capillary and vessel sealing are largely linked to collagen denaturation and shrinkage associated with higher sustained temperatures (≈T>70° C.). Tissue temperatures much higher than these can lead to non-linear behaviors (e.g., cavitation, boiling, enhanced attenuation, reflection etc.), rendering safety and control of the hemostasis process more difficult. It is extremely difficult to achieve hemostasis if dosing (acoustic energy delivery) occurs in the presence of significant intravascular blood flow (blood flowing through vessels) and/or extravascular blood flow (bleeding). Such flow dramatically dissipates thermal energy deposition, producing either subtherapeutic temperatures or a requirement to compensate with large increases in acoustic power and dosing time. Such elevated power places the skin and “interpath” tissues at higher risk for thermal/acoustic injury such as bums, obliterative coagulative necrosis, and tissue cavitation. In addition, control is rendered more challenging in light of the non-linear effects mentioned. Finally, such elevated power creates greater challenges on device thermal management, thermal stress, power-associated system weight and other related factors.
To address these complications, it is desirable to minimize bleeding from the target injury site(s) during dosing. In the case of extreme combat trauma (e.g. fast bleeders in multiple vessels), it may be advantageous to dose in the absence of limb perfusion altogether. By minimizing the injury bleeding and perfusion one can deposit the acoustic energy at the bleed site without having to compensate for energy being swept away through bleeding in the treatment volume. Such bleeding dissipates the acoustic energy, which lowers the tissue temperatures during the power dose period. The effect of this dissipation is a) to reduce efficacy (e.g. reduced coagulation and collagen cross-linking, mechanisms that help with affecting the seal) due to lower temperatures, or b) to require the addition of significant therapeutic acoustic power to maintain the desired therapeutic temperatures.
Accordingly, in one embodiment, a liquid and/or gas inflatable compartment (bladder) is integrated into a deep bleeder acoustic coagulation (DBAC) acoustic hemostasis cuff device. The inflatable subsystem and its control module may be used to apply compression to slow or stop bleeding during application of the acoustic therapy. This system enables the deposition of the acoustic energy at the bleed site without having to significantly compensate for energy being swept away through bleeding. Surface power reduction also lowers the risk of the patient/subject (e.g., injured soldier) experiencing burning of the skin and “interpath” tissues. The cuff may be used to provide an on-demand tourniquet so that bleeding may be minimized during device setup, treatment delays, or interruptions, thereby buying additional time in regard to risk of shock period. The cuff also permits delivery of pressure preferentially to the treated limb. A control module may be configured to automate cuff inflation and control. Additionally, the cuff may also serve as an on-demand splint for limb immobilization.
An additional benefit of providing compression during therapy is that the coupling of the sound to the treated limb for therapeutic energy delivery and acoustic targeting and detection is enhanced. Furthermore, the pliant nature of some embodiments of the cuff device facilitates acoustic coupling to tissues with irregular shaped surfaces (either normal skin, or open wounds) or limbs of various sizes. In other embodiments, the cuff device facilitates acoustic coupling by conforming to the body via liquid instead of a pliant mechanical cuff as described in more detail below.
In some embodiments where the cuff is inflated with a liquid, flow of the liquid through the cuff may be used to provide surface cooling of the skin or the wound surface of the tissue being treated, thereby further mitigating potential superficial burns. Fluid flow through the cuff may also be used to cool the array transducer surface thereby improving performance and device reliability. In addition, the cuff, whether liquid or gas filled, can be used to provide a thermal stand-off to separate a potentially hot therapeutic applicator surface from the skin.
In one embodiment, the cuff architecture may be used to provide an outer structural layer (e.g., an exoskeleton), thereby giving a fixed and (relative to the limb treatment volume) immobile support for the detection and therapy transducer arrays. In addition, the architecture may be used to control and fix the limb shape for optimal acoustic therapy as well as to provide an on-demand splint.
In one embodiment a cuff system is provided that includes components which control limb and injury bleeding during dosing and/or during detection/localization. In one embodiment, the cuff system includes a liquid-inflated compartment (bladder) surrounding the limb to be treated, with an accompanying pressurization control system. Because the liquid compartment can deliver pressure to the limb, it can both constrict limb blood flow during dosing (like a conventional blood pressure cuff at peak pressure) as well as permit controlled limb perfusion during bleeder detection when cuff pressure is released.
In automated modes the cuff pressurization can be stepped through inflation-deflation cycles in a programmed manner, and can hold pressures at desired levels (e.g. just below systole to allow big bleeders to be detected with less blood loss). Low frequency flow-disturbance associated noise in vessels, such as the well-known Korotkoff sounds used in blood pressure cuff pressure-release maneuvers, can be used as potential indicators of appropriate applied pressure for hemostasis of major arteries. Other low frequency sounds may also be useful in automated pressure control of the DBAC cuff, such as used in “vibrometry” detection of tissue and vessel wall motions. By controlling cuff pressure delivery and release venting rates, and using acoustic motion tracking algorithms, the motion of the bleeding targets in the transition between high and low cuff pressure states can be monitored. Very little cuff-tissue motion of bleeders need occur between detection and treatment phases. Further, Doppler signals from bleeders as a function of applied cuff pressure will have diagnostic value in prioritizing bleeder targets.
A liquid inflatable compartment 30 (e.g. cylindrical bladder filled with degassed water) provides adjustable compression to the limb. In the case that the compartment 30 is liquid filled, it may be acoustically coupled to the body, thereby transmitting acoustical energy from the transducers 25 to the limb. A configuration which utilizes a proximal and/or distal dam configuration (described below) may utilize either gas or liquid to inflate the pressurized dams. In both cases fluid may serve to acoustically couple ultrasound between the transducer elements 25 and the body as well as apply pressure to the limb. The patient's limb includes skin surface 35, subcutaneous fat layer 40, and muscle 45. Artery 50 and bone 55 are within the limb.
The inflatable compartment 30 holds (and delivers) pressure forces. The pressure can be delivered by providing features in the cuff that enable on-demand or automated, cuff inflation that constricts limb flood flow, in a tourniquet like fashion, e.g. similar to the operation of conventional blood-pressure cuffs that are used with Korotkoff sound detection of the sequential shutting off of blood flow and its resumption. The inflatable compartment 30 serves as an on-demand (i.e., quickly deployed and reversed) tourniquet, playing a key role in preserving patient/soldier blood volume during treatment preparation, treatment bleed site detection, or treatment delays or interruptions.
The inflated liquid-chamber architecture of the cuff device can be implemented in a variety of configurations.
In the configuration of
As discussed above, the liquid used to inflate the chambers positioned beneath the ultrasound transducers serves both the function of providing pressure to shut off (or restrict) the injury blood flow in the limbs as well as to enhance coupling of sound from the transducers to the treated limb for therapeutic energy delivery and acoustic targeting and detection. The coupling fluid may be any fluid having suitable acoustic transmission properties. In some embodiments, the fluid is water or physiologic saline (e.g., sterile, or non sterile, degassed or non-degassed water). In embodiments utilizing dams such that the coupling liquid is in direct contact with the limb/wound, pro-coagulant and/or anti-infection agents may be included in the coupling liquid to further promote hemostasis while reducing the risk of infection. A non-limiting example of a suitable pro-coagulant is thrombin. A non-limiting example of a suitable anti-infective is an antibiotic.
In addition to providing an acoustic path to the tissue, the liquid-filled compartments of the cuff also facilitate coupling in a compliant manner to tissues with irregular shaped surfaces (either normal skin, or open wounds) or limbs that vary in size (e.g., diameter). That is, the liquid-filled fluid bolus that comprises the inflated portion of the cuff would be able to accommodate the contours of the limb surface while performing acoustic coupling and limb compression force delivery.
Additionally, the cuff fluid compartment also provides, through forced convection or natural convection, surface cooling to the skin or the wound surface of the tissue being treated, thereby mitigating potential superficial bums due to the therapeutic ultrasound dosing. In some embodiments, these functions can be enhanced by providing a temperature-controlled, recirculating supply of liquid to the cuff. In some embodiments, the liquid is further processed, such as by providing degassing mechanisms to enhance the acoustic coupling properties of the liquid. The fluid compartment also serves as a thermal stand-off to separate hot therapeutic ultrasound applicator surfaces from the skin, thereby minimizing conductive heating (in addition to ultrasound absorption) contributions to superficial bum risk. Further, the fluid convection also controls the temperature of the applicator surface, potentially optimizing acoustic transducer performance and reducing thermal failure or device lifetime risks.
Some embodiments include a control system that allows cuff pressurization (or, equivalently, inflation volume) to be varied (either manually or automatically) according to whether, a) blood limb perfusion should be prohibited (or reduced), as needed for dosing requirements, b) the pressure/volume in the cuff should be reduced to permit appropriate blood flow in vessel lumens for bleeding detection and therapeutic targeting, or c) bleeding from the injury site needs to be controlled (e.g., pressurization only permitting peak systolic pressure event bleeding). Such a variable control (manual or automatic) of the cuff further enhances detection, targeting/localization, and coagulation treatment.
To enable effective application of cuff pressure for coupling, skin and transducer cooling, and bleeding control, control systems may be provided that both allow the user/operator to manually moderate the cuff inflation and that step through cuff inflation pressures in a programmed manner, alternatively localizing bleeds (during detection and localization/targeting phases) using lower inflation level periods, and then being set to higher inflation levels during dosing.
In one embodiment, the pressure delivery aspects of the inflatable cuffs may be used for controlling and fixing the limb shape for optimal acoustic therapy. For example, the cuffs may be used to put bleeder targets within optimal depth ranges for the multiple transducer modules in the cuff. In some embodiments, cylindrical or oval cross-sectional shapes for the limb may be optionally imposed via cuff pressurization strategies.
In one embodiment, the array of acoustic transducer modules is coupled to the liquid-filled compartment by having the transducer aperture surfaces protrude through the external membrane wall of the liquid-inflated chamber (
In
Using independent water panels as described above provides the advantage of being able to remove a panel and still have the cuff function (i.e., independence). In addition, if one panel's dam or individual water bladder breaks or is damaged, neighboring panels may be sufficient to provide acoustic hemostasis, acoustic bleeding detection, and the ability to reduce and/or stop bleeding via applied pressure (i.e., redundancy is built into the system). Finally, the flexible material connecting the panels to each other does not have to be water tight allowing a wider range of materials to be used between panels in order to provide for flexibility.
In some embodiments, the cuffs described above may be used by first placing an injured patient/soldier in an appropriate treatment position. A disposable sterile barrier pad may be then be wrapped around the injured limb. The barrier pad may include. acoustic coupling properties such as acoustic gel prepositions on both sides of the barrier. A deep bleeder acoustic coagulation (DBAC) cuff is then unrolled and wrapped onto the injured limb over the disposable pad and locked or strapped snugly into position. Electrical and fluid connections from the cuff to the base unit (RF power, control system, and fluids subsystem) may then be made. Alternatively, the connections may be pre-connected to save procedure time. Similarly, the fluid compartments and fluid lines may be pre-primed where possible.
Fluid compartment(s) in the cuff may be first pressurized with manual activation to achieve (a) good acoustic contact between the cuff, disposables, and limb, (b) a stable and semi-rigid deployed configuration of the cuff system and limb, and (c) hemorrhage control through cuff pressurized tourniquet action. The cuff fluid will occupy all of space between limb and conformal transducer array blanket layer. After manual activation, the operator can initiate automatic treatment, which may include repeated cycles of detection, localization, and HIFU therapy until all bleeders are sealed. The automatic programming may also adjust the pressure of the cuff in order to achieve the desired functions of detection, localization, and therapy.
Ultrasonic Array and System for Acoustic Hemostasis
The ultrasound transducers for use with any of the above described arrays may include but are not limited to conventional PZT ceramic transducers, electrostrictive transducers, capacitive microfabricated ultrasonic transducers (cMUTs), and PZT microfabricated ultrasonic transducers (pMUTs). The above systems may utilize a single set of transducers that perform low power ultrasonic detection/localization as well as high power High Intensity Focused Ultrasound (HIFU) functions. Alternatively, two sets of ultrasonic transducers may be provided for the separate purposes of optimized detection/localization and therapy. These two sets of transducers may be made of the same piezoelectric material (e.g. PZT, electrostrictor, cMUT or PMUT) or they may be a hybrid combination (e.g. a hybrid architecture whereby cMUT 2-D imaging arrays are used for detection/localization and are interlaced with the electrostrictive transducers for therapy).
In conventional 2D array designs based on PZT ceramics, the interconnection complexity is a challenge due to the small size and the large numbers of the elements. A typical 2D array with λ/2 spacing has over 4000 electrical connections, if fully sampled. This problem is exacerbated in the DBAC cuff, which is 40 cm by 80 cm in dimension. For example, a cuff operating at 1 MHz for therapy and imaging with a 0.8 mm pitch has potentially 500,000 electrical connections. These element numbers also significantly increase the multiplexing circuit complexity, implying numbers of active channels that are impractical. The DBAC driving circuit requirements add further challenges since the optimal circuit design for bleeder detection and that for therapy delivery may be different. Accordingly, in some embodiments, architectures are provided that allow for the simplification of the system complexity via the use of transducer choice and overall cuff design. Non-limiting examples of architectures that may be used include:
Electrostrictive Array Architecture: This approach uses electrostrictive transducers exclusively, with each transducer used alternatively for detection/localization and therapy. The detection and localization approach may use Doppler interrogation of the limb. The bias controlled architecture enabled by electrostrictive materials produces significant simplifications viz. PZT piezoceramic devices when it comes to channel count and interconnect complexity.
cMUT Array Architecture: This approach uses cMUTs for detection/localization and therapy, providing both therapeutic power and 3D-based targeting. This approach is architecturally similar to the electrostrictive array approach with bias control used to reduce channel count and interconnect complexity.
pMUT Array Architecture: This approach uses pMUTs for detection/localization and therapy, providing both therapeutic power and 3D-based targeting via pMUTs. This approach is architecturally similar to the electrostrictive and cMUT approach with bias control used to reduce channel count and interconnect complexity.
PZT Array Architecture: This approach uses PZT for detection/localization and therapy. This approach is potentially challenging given the high channel/interconnect count, however, micro-mechanical switches can be used to provide for a simplified design.
Hybrid Architecture: This approach uses a hybrid architecture whereby either cMUT, pMUT, PZT or Electrostrictive 2-D arrays are used for detection/localization, and are interlaced with a different type of transducer for therapy.
Unlike normal piezoelectric materials (e.g., PZT), electrostrictive materials (also termed “relaxors”) require a DC bias voltage to exhibit piezoelectric properties. When the DC bias voltage is removed, the field-induced polarization disappears and the material ceases to be piezoelectric. This means that entire groups of transducers can be turned on or off by application or removal of the bias field. As described below, this enables the number of driver channels to be greatly reduced, simplifying interconnection and control issues significantly, as well manufacturing cost and complexity. While the potential of electrostrictive materials have been demonstrated in both medical and sonar applications, commercial development has been slow due to problems encountered when attempting to implement electrostrictive transducers.
In recent years, the field-induced piezoelectric property of electrostrictive materials has been explored for medical imaging applications. Several families of relaxor-type electrostrictive materials have been studied for medical imaging applications. Of these, lead-magnesium-niobate modified with lead titanate (PMN-PT) relaxors exhibit the most desirable properties. The advantageous properties of PMN-PT materials for ultrasonic applications include large field-induced piezoelectric coefficients, comparable to PZTs; tunable transmit/receive sensitivity by adjusting the DC bias; high dielectric constant, which improves electrical impedance matching; a spectral response similar to PZT-type transducers; sensitivity and bandwidth comparable to PZT, with slightly higher sensitivity being observed in PMT-PT; relaxor properties conducive to use for both detection and high power therapy; and relatively stable transducer performance over the operating temperature range despite the fact that the dielectric constant and coupling constant is a function of temperature. Three different electrostrictive PMN-PT materials have been developed having operating temperature ranges of 0−30° C., 10−50° C. and 75−96° C., respectively.
Electrostrictive Array Architecture
In one embodiment, the architecture shown in
When a row of elements 600 is turned “on”, the focusing position, steering, focal size and power intensity is controlled through the 800 system channel 602. Any elements 600 that have the acoustic path to the bleeder obstructed by bone or metal fragments are turned off through a system channel 602. The selection of the number of rows to be turned on is determined by the depth and size of the bleeder. A Fresnel lens design concept can be used to select the voltage applied to each row. This approach provides the best beam shape for detection, localization and therapy in a cuff architecture. The beam shape and intensity can also be controlled through the magnitude of the DC bias, which shades selective parts of the aperture. For mechanical and acoustic purposes, the relaxor transducers. 600 may be grouped in rigidly mounted sub-aperture modules (e.g., 2 cm×2 cm sections) when deployed on a cuff. A detailed function block diagram of one system control channel 602 is shown in
Use of PIN Diodes for Minimizing Parallel Capacitive Loading
The commercial development of large aperture 2D transducer electrostrictive arrays having thousands of array elements has been limited due to the parallel capacitive loading that the non-activated transducer elements have on the activated elements. This capacitive loading has been identified as a major problem for imaging performance during the imaging receive mode.
In the 2D electrostrictive array described in
Accordingly, in one embodiment a PIN diode is used to form electrical connections only to the activated elements during the receive mode. The PIN diode allows only the activated elements in the 2D array to be electrically connected to the receive amplifiers, thereby reducing the parallel capacitive loading and allowing for sensitivities approaching that of 1D or 1.5D arrays. The connection may be “made” using only the electrical bias needed to activate the elements and therefore, does not require an additional actuation power distribution grid or electrical interconnects between elements.
The use of a PIN diode as a selective switch in a 2D array of bias controllable piezoelectric material elements is illustrated by the electrical schematic in
In this example, the bottom electrode of element #1610 is grounded (therefore non-activated) while elements #2612 and #3614 are biased to 600 volts, but at opposite potentials. In this described quiescent state (pulser 630 output has not been turned on), the diodes 618 and 620 connected to element #1 are not in a conductive state since there is no voltage across them. One diode 624 connected to element #2 would be conducting (shown with an arrow pointing in the direction of current flow) and would allow the top electrode to go to “one forward diode voltage drop” above ground. Also, one diode 626 connected to element #3 would be conducting and would allow the top electrode to go to “one forward diode voltage drop” below ground.
During the nominal pulse transmit period of the imaging mode or the therapeutic transmit mode, the output of the pulser 630 will have a voltage amplitude high enough to forward bias all the PIN diodes 618, 620, 622, 624, 626, and 628 in turn and electrically drive all three elements 610, 612, and 614. A pair of diodes is used because the pulser 630 drive output is bi-polar, going positive and negative. In
In receive mode (the period of time immediately following the cessation of the pulser output), the diodes return to the quiescent state described earlier. Returning acoustic echoes from the acoustical field will excite the elements 610, 612, and 614, causing small mV range signals to be produced on the activated elements. Since one of the PIN diodes connected to Element #2612 is forward biased, the small signal generated on the top electrode (the bottom electrode is AC grounded by the 600 volt rail) will couple through the PIN diode 624 and go over to the left input of the T/R switch 616, to be mirrored over to the right side, for propagation into the receive amplifier. Likewise, one of the PIN diodes connected to Element #3614 is forward biased, so the generated signal from that element will also make it to the receive amplifier. Element #1610 is not connected to the circuit, since neither corresponding PIN diode 618 or 620 is biased on, nor does it load the signal line with extraneous intrinsic capacitance.
PIN diodes attached to the elements of a 2D array as described perform the function of automatically connecting and disconnecting elements as needed for optimum array performance. In
Finally, the above-described concept can also be utilized with other diode topologies that may provide different levels of performance.
In yet another implementation, variation of the diode switch concept, the DC current bias device may be connected to a separate control/bias line rather than the high-voltage bias conducting strip. Such a configuration may provide improved switching speeds, improved crosstalk immunity between elements, or reduced power dissipation in the array.
Use of PIN Diodes to Connect 2D Array Cross Points
In another embodiment, conductive kerf fill 660 is inserted along one side of an element, and then subsequently cut to form the structure depicted by the perspective view of
Use of Electrostrictive Material in High Voltage Bypass Capacitors
Ultrasound transducers using PMN type electrostrictive ceramic materials typically require the use of a large, DC bias voltage to the element(s) for them to operate in the desired mode. Since the power supply for producing this bias voltage is usually placed in series with the element(s), it can have a detrimental effect on the AC impedance of the array as seen by the ultrasound transmitter and receiver. It is standard procedure to place a capacitor in parallel with the high voltage supply near the element(s) so that the AC signals bypass the DC supply, which effectively shorts out the impedance of the power supply and its interconnections from the perspective of the ultrasound transmitter and receivers.
In this application, the capacitor must be able to withstand a large DC bias voltage, which can be 100's to 1000's of volts. It also has a relatively large capacitance value, generally greater than 10,000 pF, to be effective at shorting the supply in the desired frequency range. This combination of requirements means that the capacitor is physically large in size using current state of the art manufacturing methods (e.g., a 10,000 pF, 1,000 v, ceramic capacitor is typically a disc that measures 22 mm in diameter and 5 mm thick). For single element transducers, this large capacitor can be tolerated since only one capacitor is required. However, when building an array of elements, many bypass capacitors may be required because there are many individual elements in the array. As the number of capacitors increases, the amount of volume required for them can become impractical when a small, fine-pitched array is desired.
Accordingly, in some embodiments, the bypass capacitors are constructed using the same PMN material and construction methods as used in the transducer itself. Because of the unique properties of the PMN material and by constructing the capacitors along with the array, the volume used by the capacitors is thereby greatly reduced. Thus, an array of high voltage, high capacitance bypass capacitors can be constructed in a very small volume. This small volume makes the capacitor array practical for use with a 2 dimensional ultrasound transducer built from PMN material. This construction method also allows the capacitance values to be adjusted over a wide range without limitations of commercial, off-the-shelf availability. The value of the capacitors can be easily adjusted by varying the size of the plates during their manufacture.
In some embodiments, the capacitor array can be built in such a way that the interconnection of the capacitors to the transducer is relatively easy to accomplish using similar bond-wire interconnection techniques that are used for other connections on the transducer. In contrast, commercially available capacitors typically use interconnection methods that are more suited to printed circuit board assembly and are difficult to work with at the finer scale of an ultrasound transducer.
The capacitors can be constructed with a dielectric material that is identical to the material used in the transducer. Thus, the performance characteristics, such as temperature range, operating frequency and dielectric strength, of the capacitor will be matched to the transducer it is mated with. In contrast, commercial capacitors typically use ceramic dielectric formulations that are best suited for other applications, which may result in insufficient performance for certain specifications.
It has been discovered that a 0.5 mm thick element improves in performance as the voltage is increased. A bias voltage of 400 V DC appears to be near the “knee of the curve” such that below that voltage, the performance is poor. Above 400 V the efficiency of the acoustic output continues to increase but at a slower rate than below 400 V. Thus, for a 0.5 mm element, 400 V is the preferable minimum usable bias voltage. When thicker elements are used, which may be desired in order to achieve resonance close to 1 MHz, a proportionally higher bias voltage can be used. Thus, a typical minimum value for voltage tolerance on the bypass capacitor is 1000 V or more. As noted above, the current state of the art in off-the-shelf capacitors of this rating provide a maximum capacitance of 0.01 uF in a disk that is 22 mm diameter by 5 mm thick. Custom parts or more exotic materials may produce smaller or higher capacitance, but cost and delivery times go up substantially.
An ideal bypass capacitor would exhibit near zero impedance at the frequency of interest or at least be substantially lower in impedance than the piezoelectric element and substantially lower impedance than the cable and power supply it is bypassing. At a nominal frequency of 1.5 MHz, which is approximately where a therapeutic transducer might be designed to operate, the 0.01 uF capacitor will have an impedance of 10.6 ohms. This is probably higher than would be desired, which means even the largest available capacitor in the 1 kV rating is less than ideal.
As an alternative, consider the equation for the capacitance of a device:
C=Cr*8.85 pF/meter*A/D
where:
One of the useful properties of PMN ceramic is its very high dielectric constant. The exact value varies with formulation, temperature and bias level, but 15,000 is a reasonable average value. By plating both sides of a 1 cm square wafer of PMN that is 0.5 mm thick, a capacitor of 0.026 uF is produced. Thus, a simple plated wafer of the same material used for a transducer can produce a capacitor that is 2.5 times as large as the commercial version in a fraction of the space. Another property of PMN is its high dielectric strength, which is specified as having a working range up to 10 Kv/cm and will withstand values well beyond that. The thickness of the PMN can be tailored as can the area of the plating to optimize the capacitance and the voltage rating. Allowing for some space on the sides of the wafer to attach bond wires, insulation, and space between them, the wafers can be placed side-by-side on a pitch of 2 mm. The 20 capacitors required for the example array described above would then require a cube that is 1 cm×1 cm×4 cm. Or alternatively a cube that is 1 cm×2 cm×2 cm.
The capacitors may be built from 1 cm×2 cm×0.5 mm wafers of PMN material. Each wafer is copper plated on both sides. One side is used for ground and is fully plated. The other side is used for the DC voltage connections and the plating is split in the middle into two separate plates. In this configuration, each wafer would make two capacitors that are approximately 1 cm×1 cm each. To prevent acoustic coupling between the two capacitors, the PMN material may be completely split and then kerf-filled between the two halves.
To assemble the capacitor array, a mechanical framework can be built that holds ten of the 1 cm×2 cm capacitor assemblies side by side as shown in the perspective view of
When assembling the capacitor wafers into an array, care must be taken to prevent electrical breakdown due to the high voltages that are being handled. The gap between the two HV plates on each wafer may be made wide enough for electrical isolation and covered with a good dielectric. This gap may experience twice the voltage differential of the high voltage supply since one side may have a positive bias and the other may be negative. The edges of the wafers can be covered with a strong dielectric material to prevent arcing across the edge of the PMN. The bonding foil and the connections to the transducer may also be adequately insulated from one another to prevent arcing across them.
Use of Non-activated Elements as Intrinsic High Voltage Bypass Capacitors
As mentioned in the previous section, an important design consideration of bias controlled 2D arrays is the need to have a low impedance ground path for all the elements along a common high-voltage strip, normally provided by the addition of a bypass capacitor in the circuit. An example of this typical bypass solution is depicted in
In one embodiment, non-activated elements of a 2D array are used to provide the bypass capacitance, eliminating or reducing the size of additional bypass capacitors. As discussed above, a given element in a electrostrictive transducer array is only activated if a DC high-voltage bias is applied by the electrically conductive strip above and simultaneously, an AC drive signal from below. Elements which have no DC bias applied appear as electrical capacitors only and lack any acoustic-electric transforming properties. By extension, it is possible to select an active acoustic “aperture”, which is the set of all elements that have a DC high-voltage bias applied and are also connected to an AC drive Transmit/Receive circuit. In these configurations, the added bypass capacitor needed for optimal detection (e.g. imaging) performance can be reduced, possibly to the point of not being required at all. This is significant because the bypass capacitor required (high voltage and fairly high capacitance) is physically large, which could limit certain useful applications (e.g., the DBAC cuff described above).
In a large 2D array of elements, where there are more elements than the nominal sized active aperture, there will usually be elements that are not activated. For bias controllable piezoelectric materials (such as PMN-PT) and potentially other bias controlled MEM structures (such as C-MUT or P-MUT), these non-activated elements still possess electrically capacitive properties, even though their electro-acoustic characteristics have not been switched on.
In
In some embodiments, certain elements may be grounded instead of being left open. The circuit diagram then would reduce to the slightly different schematic depicted in
Although the invention has been described with reference to embodiments and examples, it should be understood that numerous and various modifications can be made without departing from the spirit of the invention. Accordingly, the invention is limited only by the following claims.
The present application claims priority to U.S. Provisional Applications 60/699,275 filed on Jul. 13, 2005, 60/699,253 filed on Jul. 13, 2005 and 60/699,290 filed on Jul. 13, 2005, all of which are incorporated herein by reference in their entirety.
The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided for by the terms of Contract No. W81XwH-06-C-0061 entitled “Noninvasive Acoustic Coagulation System for Life Threatening Battlefield Extremity Wounds” awarded by the Defense Advance Research Projects Agency (DARPA).
Number | Date | Country | |
---|---|---|---|
60699275 | Jul 2005 | US | |
60699253 | Jul 2005 | US | |
60699290 | Jul 2005 | US |